| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 1.66B | 2.21B | 2.20B | 2.05B | 1.87B | 1.82B |
| Gross Profit | 783.55M | 1.04B | 1.01B | 900.40M | 836.20M | 790.50M |
| EBITDA | 348.50M | 473.90M | 457.60M | 431.40M | 358.60M | 340.20M |
| Net Income | 181.05M | 248.50M | 237.30M | 226.30M | 196.30M | 170.20M |
Balance Sheet | ||||||
| Total Assets | 2.50B | 2.49B | 2.47B | 2.52B | 2.17B | 1.98B |
| Cash, Cash Equivalents and Short-Term Investments | 123.60M | 150.00M | 108.20M | 135.00M | 97.50M | 211.00M |
| Total Debt | 859.20M | 695.50M | 745.10M | 945.00M | 717.40M | 524.10M |
| Total Liabilities | 1.58B | 1.41B | 1.44B | 1.61B | 1.39B | 1.18B |
| Stockholders Equity | 914.80M | 1.09B | 1.03B | 905.60M | 779.10M | 799.50M |
Cash Flow | ||||||
| Free Cash Flow | 255.75M | 280.10M | 283.30M | 193.20M | 199.60M | 267.30M |
| Operating Cash Flow | 307.20M | 371.60M | 363.20M | 264.50M | 257.10M | 318.00M |
| Investing Cash Flow | -114.10M | -58.00M | -69.10M | -278.00M | -234.40M | -73.00M |
| Financing Cash Flow | -232.20M | -276.20M | -276.40M | 24.50M | -109.40M | -146.60M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | £6.45B | 27.97 | 23.79% | 1.29% | -0.32% | -3.96% | |
75 Outperform | £7.84B | 25.61 | 17.68% | 1.26% | -1.97% | 40.55% | |
73 Outperform | £1.74B | 43.94 | 35.23% | 1.01% | 24.42% | 103.25% | |
72 Outperform | £5.20B | 31.98 | 14.19% | 2.46% | 0.10% | -15.33% | |
66 Neutral | £2.75B | 28.32 | 16.97% | 2.04% | 1.93% | -15.07% | |
66 Neutral | £7.77B | 28.70 | 12.85% | 1.93% | -6.93% | 18.57% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |
IMI plc has disclosed that three senior executives — Chief Executive Officer Roy Twite, Chief Financial Officer Luke Grant and Chief People Officer Elizabeth Rose — have each purchased small tranches of IMI ordinary shares through the company’s Employee Share Ownership Plan. The transactions, executed on 13 January 2026 at a price of £26.18 per share and reported under Market Abuse Regulation requirements, modestly increase the leadership team’s direct equity stakes and underscore ongoing alignment between management and shareholders through structured share purchase schemes.
The most recent analyst rating on (GB:IMI) stock is a Hold with a £2500.00 price target. To see the full list of analyst forecasts on IMI plc stock, see the GB:IMI Stock Forecast page.
IMI plc reported that as of 31 December 2025 its issued share capital comprised 259,654,876 ordinary shares, of which 12,648,836 are held in treasury. This leaves a total of 247,006,040 voting rights in the company, a key reference figure shareholders must use to assess whether they are required to disclose holdings or changes in holdings under UK Financial Conduct Authority disclosure and transparency rules.
The most recent analyst rating on (GB:IMI) stock is a Hold with a £2500.00 price target. To see the full list of analyst forecasts on IMI plc stock, see the GB:IMI Stock Forecast page.
IMI plc, a company involved in the manufacturing and engineering sector, has announced transactions by its senior management as part of the IMI Employee Share Ownership Plan. The Chief Executive Officer, Chief Financial Officer, and Chief People Officer have each purchased shares at a price of £24.76 per share on the London Stock Exchange. This move reflects the company’s commitment to aligning management interests with those of shareholders, potentially enhancing stakeholder confidence.
The most recent analyst rating on (GB:IMI) stock is a Buy with a £2772.00 price target. To see the full list of analyst forecasts on IMI plc stock, see the GB:IMI Stock Forecast page.
IMI plc announced its current issued share capital consists of 259,653,401 ordinary shares, with 12,648,836 held in Treasury, resulting in 247,004,565 total voting rights. This update is crucial for shareholders to determine their notification requirements under the FCA’s Disclosure and Transparency Rules, impacting how they manage their interests in the company.
The most recent analyst rating on (GB:IMI) stock is a Hold with a £2550.00 price target. To see the full list of analyst forecasts on IMI plc stock, see the GB:IMI Stock Forecast page.
IMI plc has announced the sale of its Truflo Marine business to Fairbanks Morse Defense for an enterprise value of £225 million. This strategic move is part of IMI’s focus on aligning with growth trends in energy, automation, and healthcare, which are expected to drive sustainable growth. The transaction, pending regulatory approvals, is anticipated to complete by mid-2026. IMI’s CEO expressed confidence in Fairbanks Morse Defense as a suitable new home for Truflo Marine, highlighting their commitment to investing in the business’s success.
The most recent analyst rating on (GB:IMI) stock is a Buy with a £28.10 price target. To see the full list of analyst forecasts on IMI plc stock, see the GB:IMI Stock Forecast page.
IMI plc announced transactions involving its top executives, including CEO Roy Twite, CFO Luke Grant, and Chief People Officer Elizabeth Rose, who purchased shares under the IMI Employee Share Ownership Plan. These transactions, conducted on the London Stock Exchange, reflect the executives’ commitment to the company’s growth and align their interests with those of shareholders, potentially impacting the company’s market perception positively.
The most recent analyst rating on (GB:IMI) stock is a Buy with a £28.10 price target. To see the full list of analyst forecasts on IMI plc stock, see the GB:IMI Stock Forecast page.
IMI plc reported an excellent third quarter performance with a 12% increase in organic revenue compared to the same period last year, and a 5% increase year to date. The company is on track to achieve its fourth consecutive year of mid-single digit organic revenue growth, driven by strong performances in the Process Automation sector and other market sectors like Climate Control and Life Science & Fluid Control. The company reconfirmed its full-year guidance, highlighting its strong balance sheet and cash generation capabilities, which allow for investments in growth and shareholder returns.
The most recent analyst rating on (GB:IMI) stock is a Hold with a £2500.00 price target. To see the full list of analyst forecasts on IMI plc stock, see the GB:IMI Stock Forecast page.
IMI plc announced its current issued share capital consists of 259,652,973 ordinary shares, with 12,648,836 held in Treasury, resulting in 247,004,137 total voting rights. This figure is crucial for shareholders to determine their notification requirements under the FCA’s Disclosure and Transparency Rules.
The most recent analyst rating on (GB:IMI) stock is a Hold with a £2500.00 price target. To see the full list of analyst forecasts on IMI plc stock, see the GB:IMI Stock Forecast page.
IMI plc, during its 2025 Annual General Meeting, encountered a situation where Special Resolution B, concerning the authority to allot securities for cash, did not achieve the 80% support threshold as per the UK Corporate Governance Code, garnering only 78.25% support. This shortfall was attributed to institutional voting policies and concerns about potential dilution without a specific transaction in mind. The company’s board remains committed to engaging with shareholders to address these concerns and will provide further updates in its 2025 Annual Report.
The most recent analyst rating on (GB:IMI) stock is a Buy with a £2490.00 price target. To see the full list of analyst forecasts on IMI plc stock, see the GB:IMI Stock Forecast page.